Trial Summary Domain from IG 3.1.2 to 3.1.3 Dieter Boß September 2012.

Slides:



Advertisements
Similar presentations
Take a tour of De Gruyter Online
Advertisements

TWO STEP EQUATIONS 1. SOLVE FOR X 2. DO THE ADDITION STEP FIRST
My AmeriCorps State and National Reports as an Information Tool
Principal Statistical Programmer Accovion GmbH, Marburg, Germany
SDTM Implementation Guide Version 3.1.2
Slide 1 Insert your own content. Slide 2 Insert your own content.
Chapter 1 The Study of Body Function Image PowerPoint
1 Take a tour of De Gruyter Online Join the rally and learn how to navigate through our website.
By D. Fisher Geometric Transformations. Reflection, Rotation, or Translation 1.
Quest ion 1? A.) answer B.) answer C.) correct answerD.) answer L C.) correct answer F.
Labeling claims for patient- reported outcomes (A regulatory perspective) FDA/Industry Workshop Washington, DC September 16, 2005 Lisa A. Kammerman, Ph.D.
FDA/Industry Statistics Workshop - 29 September 2006
FDA/Industry Workshop September, 19, 2003 Johnson & Johnson Pharmaceutical Research and Development L.L.C. 1 Uses and Abuses of (Adaptive) Randomization:
Building a National Medication Reference Terminology:
Aspects of DICOM for Patient Safety
Event, date: Reporting of SoE biology, Author: Jannicke Moe (NIVA) 1 Agenda item 2: Practical information for reporting of State-of-Environment.
Title Subtitle.
CEDARS Statewide: February 9, 2012 Webinar Bilingual Validations Common CEDARS Questions HQT Questions relating to CEDARS Logical Deletes – threshold settings.
0 - 0.
DIVIDING INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
SUBTRACTING INTEGERS 1. CHANGE THE SUBTRACTION SIGN TO ADDITION
MULT. INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
Teacher Name Class / Subject Date A:B: Write an answer here #1 Write your question Here C:D: Write an answer here.
Addition Facts
Relational data integrity
EMC Digital Universe Study 2012 iView Graphics. Terms of use Written Permission If you wish to quote or use IDC materials (graphics) in an ad, press release,
1www.visuel-vox.com Live Broadcasting Text in France Transcription in Real Time and Broadcasting Text.
Investigational Device Exemption (IDE) Overview for IRBs
1 CIFTclinic 1.1 Software for Clinics. 2 CIFTclinic Software for Medical Clinics, which addresses the requirements of practicing doctors to automate Medical.
5.9 + = 10 a)3.6 b)4.1 c)5.3 Question 1: Good Answer!! Well Done!! = 10 Question 1:
Twenty Questions Subject: Twenty Questions
© 2012 National Heart Foundation of Australia. Slide 2.
Structured Product Labeling Overview
Limits (Algebraic) Calculus Fall, What can we do with limits?
1 Overview of Testing Methodology Obtain generic Test Scripts Populate Self Testing Work Paper Template Prepare actual test scripts Determine sample Combine.
Addition 1’s to 20.
25 seconds left…...
School Census Summer 2010 Headlines 1 Jim Haywood Product Manager for Statutory Returns Version 1.0.
Test B, 100 Subtraction Facts
Page 1 of 16 Royalty Reporting is an online service available in the Electronic Transfer System (ETS). It provides the functionality of electronic submission.
Week 1.
Paula M. Jacobs, Ph.D. SAIC Frederick Cancer Imaging Program/DCTD/NCI/NIH September 5, 2006 Phase 0 Trials in Oncologic Drug Development DCTD Phase 0 Workshop.
Bottoms Up Factoring. Start with the X-box 3-9 Product Sum
1 Unit 1 Kinematics Chapter 1 Day
Center for Clinical Research - Clinical Trials Center (CTC) Clinical Research and Clinical Trials in Switzerland Jürg Lustenberger, PhD Dipl. Pharm. Med.
Page 1 of 14 The Work in Progress screen enables the user to search for, view or open for editing applications not yet submitted, and view applications.
U.S. Food and Drug Administration
Unique Device Identifier (UDI) - Overview 6/21/2014
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Working with FDA: Biological Products and Clinical Development IND Regulatory.
Life Sciences Accelerated R&D Services The Science of Getting Products to Patients Faster Study Data Standardization Plan Use Case Experience Dave Izard.
DRAFT Guidance for Industry: Providing Regulatory Submissions in Electronic Format – Drug Establishment Registration and Drug Listing Denise Sánchez, J.D.,
11 February 2008NLM BOR WG on Clinical Trials1 Clinical Trials Registration and Results Reporting: Legislative Requirements Jerry Sheehan Assistant Director.
CBER CDISC Test Submission Dieter Boß CSL Behring, Marburg 20-Mar-2012.
© 2011 Octagon Research Solutions, Inc. All Rights Reserved. The contents of this document are confidential and proprietary to Octagon Research Solutions,
Overview and feed-back from CDISC European Interchange 2008 (From April 21 st to 25 th, COPENHAGEN) Groupe des Utilisateurs Francophones de CDISC Bagneux.
HL7 RCRIM Meeting: 9 January 2007 CDISC-RCRIM Vocab Update: Related CDISC Terminology Projects Bron Kisler, CDISC Terminology Program Director
Key Compliance Risks in Clinical Trials Kathleen Meriwether Principal, ERNST & YOUNG, LLP Fraud Investigation & Dispute Services.
Clinical Research Data Capture (CRD) IHE Vendor’s Workshop 2008 IHE Quality, Research, and Public Health (QRPH) Jason Colquitt Greenway Medical Technologies.
Research Study Data Standards Standards for research study data for submission to regulatory authorities Standard development divided into three parts:
Federal Medication Terminologies (FMT) Enabling Health IT Interoperability.
How good is your SEND data? Timothy Kropp FDA/CDER/OCS 1.
ClinicalTrials.gov Requirements
Assign membership into BFO/OBI branches
Secondary Uses Primary Use EHR and other Auhortities Clinical Trial
Networking and Health Information Exchange
CPT and Disclosure: Connecting Critical Processes
BR&R Biomedical Research & Regulation
CPT and Disclosure: Connecting Critical Processes
SDTM and ADaM Implementation FAQ
An FDA Statistician’s Perspective on Standardized Data Sets
Presentation transcript:

Trial Summary Domain from IG to Dieter Boß September 2012

2 Purpose of Trial Summary Domain Submit summary of study in structured format Characteristics of trial, e.g., Protocol title Phase Randomization Primary and secondary objectives Actual characteristics like number of subjects, data cut-off dates Information is provided in findings structure 20-Aug-12

3 Trial Summary Specific Contents Standardized parameters – TSPARM Listed in CDISC Controlled Terminology (CCT) core concept: required, expected, permissible Standard code lists or formats assigned to many parameters Core concept reflects requirements for study protocol disclosure in publicly available clinical trial registries like CT.GOV Values – TSVAL Null Flavor Values – TSNVAL Since Trial Summary Update to To provide standardized missing codes for not available required parameters, e.g., NA 20-Aug-12

4 Changes from IG 3.1.2TS UpdateIG 3.1.3CCT No of parameters Required-28 - Conditionally Required (incl. If Applicable) Aug-12

5 Trial Summary Parameters in CCT CCT does not contain parameters AGEU DESIGN Does contain parameters DOSE DOSU DOSFRQ ROUTE not listed any more in list of required or expected parameters 20-Aug-12

6 Issues with Parameter List Information not always easily retrievable in study protocols Company standards needed to make TS useful within company and for submissions Code Lists are available for majority of parameters Dont invent if available There are issues with a few special code lists 20-Aug-12

7 Code List Issues SNOMED Systemized Nomenclature of Medicine Used for: Trial Indication - INDIC Diagnosis Group - TDIGRP Not licenced in many companies Can other dictionary or sponsor terms be used? 20-Aug-12

8 Code List Issues NDF RT National Drug File – Reference Terminology Can be found via NCI website Used for: Pharmocological Class – PCLAS Hard/ Impossible for data managers to identify correct term for products in development 20-Aug-12

9 Code List Issues UNII Unique Ingredient Identifier Connects to NCI Concept Code Used for: Investigational Therapy or Treatment – TRT 20-Aug-12

10 Code List Issues SRS Preferred Substance Name FDA Substance Registration System Can be found via FDA website Uses UNII codes and terms Used for: Comparative Treatment - COMPTRT Current Treatment – CURTRT Only available for approved substances ? 20-Aug-12

11 UNII is Accessible via SRS 20-Aug-12

12 Code List Issues DUNS Dun and Bradstreet System to uniquely identify companies Recommeded by ISO Used for: Clinical Study Sponsor – SPONSOR Unclear how to retrieve information Download ? 20-Aug-12

13 Access to NDF-RT and UNII 20-Aug-12

14 Thank You! Questions? 20-Aug-12